HomeT3X • FRA
add
Telix Pharmaceuticals Ltd
Previous close
€17.73
Day range
€16.22 - €16.33
Year range
€9.60 - €26.00
Market cap
9.33B AUD
Avg Volume
2.32K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
TipRanks
15 hours ago
Telix Pharmaceuticals to Showcase Radiotherapeutic Advances in Urologic
Oncology
3.76%
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 209.62M | 48.82% |
Operating expense | 111.40M | 49.65% |
Net income | 10.13M | 3.76% |
Net profit margin | 4.83 | -30.30% |
Earnings per share | — | — |
EBITDA | 18.72M | 62.79% |
Effective tax rate | 5.19% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 710.35M | 476.41% |
Total assets | 1.52B | 273.54% |
Total liabilities | 948.22M | 268.89% |
Total equity | 568.21M | — |
Shares outstanding | 329.55M | — |
Price to book | 10.43 | — |
Return on assets | 2.92% | — |
Return on capital | 3.85% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 10.13M | 3.76% |
Cash from operations | 1.97M | -62.84% |
Cash from investing | -44.67M | -295.22% |
Cash from financing | 318.38M | 11,509.30% |
Net change in cash | 295.75M | 7,065.49% |
Free cash flow | -47.94K | -100.60% |
About
Founded
2015
Website
Employees
423
